APSR2026-828

Yes
Late-Breaking
Submitted
Poster Presentation
 
AP12-054
P131
 
Format: PPTX Only
https://storage.unitedwebnetwork.com/files/1285/1219919-46904-AP12-054 (Hidden in the airway, when bronchiectasis is the first sign of systemic vasculitis)_434100.pdf
Format: PDF Only
16. Interstitial Lung Disease
3

No more than 15 authors can be listed.
Please ensure the authors are listed in the right order.
If there are multiple affiliations, please use the "+" button next to "Select Country/Region" to add additional affiliation fields.

Wei Han Hoh * Institut Perubatan Respiratori (IPR) Respiratory Department Kuala Lumpur Malaysia
Siti Afifah Amri - Hospital Sultanah Nora Ismail Internal Medicine Department Batu Pahat, Johor Malaysia
Syazatul Syakirin Sirol Aflah - Institut Perubatan Respiratori (IPR) Respiratory Department Kuala Lumpur Malaysia
 
 
 
 
 
 
 
 
 
 
 
 
Presenting Author Details
Wei Han
Hoh
ivanhohwh89@gmail.com
+60122800391
31-40
Malaysia
Case Report
Hidden in the Airway: When Bronchiectasis is the First Sign of Systemic Vasculitis.
Maximum 25 words
Abstract Content
 
 
 
 
Bronchiectasis is increasingly recognized as a clinical syndrome with diverse underlying aetiologies. Even in older adults, late-onset bronchiectasis requires a meticulous diagnostic to determine the cause. This case highlights the importance of identifying etiological "treatable traits" to prevent systemic progression.
A 61-year-old Malay lady presented with a chronic productive cough and progressive dyspnoea. Radiographic imaging confirmed presence of bronchiectasis. Initial management focused on lung targeted treatment, including airway clearance techniques and targeted antibiotic therapy for Pseudomonas aeruginosa isolated from sputum. A thorough investigation into the underlying cause was initiated despite her age and without any prior comorbidities. Serological testing revealed strongly positive MPO-ANCA, ANA positivity, and low complement C3. While initially presenting with isolated respiratory symptoms, she developed a "full-blown" systemic vasculitis crisis several months later. This included non-blanchable petechial rash (biopsy-proven leukocytoclastic vasculitis), acute kidney injury with proteinuria, and severe left ventricular systolic dysfunction (EF 25%) with pericardial effusion. The diagnosis was revised to MPO-positive ANCA-associated vasculitis (AAV) with multiorgan involvement. She was treated with pulse intravenous methylprednisolone, followed by oral corticosteroids and rituximab, facilitated by multidisciplinary collaboration.
This case underscores that bronchiectasis management must extend beyond symptomatic relief. By adopting the "treatable traits" paradigm, clinicians should systematically categorize targets accordingly. Identifying a systemic cause, even in patients over 50 is essential to transition from general supportive care to individualized, actionable interventions that address the root of pathology.
 
 
No
No
 
JPG or JPEG or PNG format ONLY
ANCA-associated vasculitis, bronchiectasis, multiorgan involvement
maximum 3 keywords and no abbreviations, separated by commas
Nil
229